Monoclonal antibodies in cancer therapy

Current Medicinal Chemistry - Anti-Cancer Agents

Volumn 4, Issue 5, 2004, Pages 411-414

  Gatto, Barbara ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Biotechnology; Cancer therapy; Chimeric Mabs; Conjugated Mabs; Fully human Mabs; Humanized Mabs; Mabs; Monoclonal antibodies

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; EDRECOLOMAB; GEMTUZUMAB OZOGAMICIN; IBRITUMOMAB TIUXETAN; IRINOTECAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BX EGF; PACLITAXEL; RITUXIMAB; TOSITUMOMAB I 131; TRASTUZUMAB; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; B CELL LEUKEMIA; B CELL LYMPHOMA; BREAST CANCER; CANCER IMMUNOTHERAPY; CARDIOTOXICITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; COLON CARCINOMA; COLORECTAL CANCER; DRUG APPROVAL; DRUG CYTOTOXICITY; DRUG INDICATION; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG TARGETING; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY CANCER; LUNG CANCER; LUNG NON SMALL CELL CANCER; NONHODGKIN LYMPHOMA; NONHUMAN; PROSTATE CANCER; REVIEW; SOLID TUMOR;

ANTIBODIES, MONOCLONAL; BIOTECHNOLOGY; CLINICAL TRIALS; HUMANS; NEOPLASMS;

EID: 4444325508     PISSN: 15680118     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568011043352713     Document Type: Review

References (38)

1. Nagle, T.; Berg, C.; Nassr, R.; Pang, K. Nature Reviews Drug Disc., 2003, 2, 75-79.
2. Drews, J. Drug Disc. Today, 2003, 8, 411-420.
3. Thayer, A. Modern Drug Disc., 2004, 7, 29.
4. PhRMA, 2002 Survey: Biotechnology, 2002.
5. Welsh, G. Nature Biotechnol., 2003, 21, 865-870.
6. Davies, N.; Peakman, T,; Arlington, S. Drug Disc. Today, 2004, 9, 197-199.
7. Cleaves, K. Modern Drug Disc., 2004, 7, 25-27.
8. Slamon, D. J.; Leyland Jones, B.; Shak, S.; Fuchs, H.; Paton, V.; Bajamonde, A.; Fleming, T.; Eiermann, W.; Wolter, J.; Pegram, M.; Baselga, J.; Norton, L. N. Engl. J. Med., 2001, 344, 783-92.
9. Reichert, J.; Pavlou, A. Nature Reviews Drug Disc., 2004, 3, 383-384.
10. Köhler, G.; Milstein, C. Nature, 1975, 256, 495-7.
11. Whelan, M.; Whelan, J.; Russell, N.; Dalgleish, A. Drug Disc. Today, 2003, 8, 253-258.
12. Nielsen, U. B.; Adams, G. P.; Weiner, L. M.; Marks, J. D. Cancer Res., 2000, 60, 6434-6440.
13. Holliger, P.; Prospero, T.; Winter, G. Proc. Natl. Acad. Sci. USA, 1993, 90, 6444-8.
14. Holliger, P.; Wing, M.; Pound, J. D.; Bohlen, H.; Winter, G. Nature Biotechnol., 1997, 15, 632-6.
15. Hudson, P.; Souriau, C. Nature Med., 2003, 9, 129-134.
16. Reichert, J. Nature Biotechnol., 2001, 19, 819-822.
17. Green, L. L. J. Immunol. Methods, 1999, 231, 11-23.
18. Brekke, O. H.; Sandlie, I. Nature Reviews Drug Disc., 2003, 2, 52-62.
19. Olsen, N.; Stein, C. N. Engl. J. Med., 2004, 350, 2167-2179.
20. Glennie, M.; de Winkel, J. Drug Disc. Today, 2003, 8, 503-510.
21. Weiner, L. M.; Carter, P. Nature Biotechnol., 2003, 21, 510-511.
22. Gelderman, K. A.; Tomlinson, S.; Ross, G. D.; Gorter, A. Trends Immunol., 2004, 25, 158-164.
23. Clynes, R. A.; Towers, T. L.; Presta, L. G.; Ravetch, J. V. Nature Med., 2000, 6, 443-6.
24. Houghton, A. N.; Scheinberg, D. A. Nature Med., 2000, 6, 373-4.
25. Milenic, D.; Brady, E.; Brechbiel, M. Nature Reviews Drug Disc., 2004, 3.
26. Wiseman, G. A.; Leigh, B.; Erwin, W. D.; Lamonica, D.; Kornmehl, E.; Spies, S. M.; Silverman, D. H.; Witzig, T. E.; Sparks, R. B.; White, C. A. Cancer, 2002, 94, 1349-57.
27. Zein, N.; Sinha, A. M.; McGahren, W. J.; Ellestad, G. A. Science, 1988, 240, 1198-201.
28. Ross, J. S.; Gray, K.; Gray, G. S.; Worland, P. J.; Rolfe, M. Am. J. Clin. Pathol., 2003, 119, 472-485.
29. Goekbuget, N.; Hoelzer, D. Ann. Hematol., 2004, 83, 201-205.
30. Foon, K. A.; John, W. J.; Chakraborty, M.; Sherratt, A.; Garrison, J.; Flett, M.; Bhattacharya Chatterjee, M. Clin. Cancer Res. 1997, 3, 1267-76.
31. Durrantt, L. G.; Spendlove, I. Expert Opin. Emerg. Drugs, 2003, 8, 489-500.
32. Slamon, D. J.; Clark, G. M.; Wong, S. G.; Levin, W. J.; Ullrich, A.; McGuire, W. L. Science, 1987, 235, 177-82.
33. Carter, P.; Presta, L.; Gorman, C. M.; Ridgway, J. B.; Henner, D.; Wong, W. L.; Rowland, A. M.; Kotts, C.; Carver, M. E.; Shepard, H. M. Proc. Natl. Acad. Sci. USA, 1992, 89, 4285-9.
34. Pegram, M.; Hsu, S.; Lewis, G.; Pietras, R.; Beryt, M.; Sliwkowski, M.; Coombs, D.; Baly, D.; Kabbinavar, F.; Slamon, D. Oncogene, 1999, 18, 2241-51.
35. Mitchell, P. Nature Biotechnol., 2004, 22, 363-364.
36. Folkman, J. N. Engl. J. Med., 1971, 285, 1182-1186.
37. Ferrara, N.; Hillan, K.; Gerber, H.-P.; Novotny, W. Nature Reviews Drug Disc., 2004, 3, 391-400.
38. Gura, T. Nature, 2002, 417, 584-586.